Article Text

Download PDFPDF
The use of interferon beta in relapsing-remitting multiple sclerosis
  1. L J Etheridge1,
  2. D W Beverley2,
  3. C Ferrie3,
  4. E McManus2
  1. 1Bradford Royal Infirmary, UK
  2. 2York Hospital, UK
  3. 3Leeds General Infirmary, UK
  1. Correspondence to:
    Dr D W Beverley
    Consultant Paediatrician, York Hospital, Wigginton Road, York YO31 8HE, UK; David.W.BeverleyYork.nhs.uk

Abstract

The use of interferon beta-1a to treat multiple sclerosis in a child of 7 years of age is discussed. To date, there is only one other published report of the use of interferon beta in a child as young as this. One year after commencing treatment she had shown significant clinical improvement, with a marked reduction in number of relapses. In her second year of treatment she suffered a major relapse from which she slowly recovered.

  • multiple sclerosis
  • interferon beta

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.